Quad-Cities Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-20,487
Closed -$569K 181
2024
Q1
$569K Sell
20,487
-1,697
-8% -$47.1K 0.33% 78
2023
Q4
$656K Sell
22,184
-1,221
-5% -$36.9K 0.41% 64
2023
Q3
$776K Sell
23,405
-492
-2% -$17.4K 0.52% 47
2023
Q2
$877K Buy
23,897
+11
+0% +$428 0.57% 41
2023
Q1
$975K Sell
23,886
-873
-4% -$37.7K 0.67% 36
2022
Q4
$1.27M Buy
24,759
+15
+0.1% +$719 0.93% 28
2022
Q3
$1.08M Buy
24,744
+17
+0.1% +$826 0.84% 31
2022
Q2
$1.3M Buy
24,727
+14
+0.1% +$713 0.96% 24
2022
Q1
$1.28M Buy
24,713
+161
+0.7% +$8.35K 0.82% 28
2021
Q4
$1.45M Sell
24,552
-89
-0.4% -$4.41K 0.91% 27
2021
Q3
$1.06M Sell
24,641
-467
-2% -$20.7K 0.74% 37
2021
Q2
$983K Sell
25,108
-155
-0.6% -$6.03K 0.67% 41
2021
Q1
$915K Sell
25,263
-2
-0% -$71 0.69% 36
2020
Q4
$930K Sell
25,265
-1,249
-5% -$45.8K 0.76% 33
2020
Q3
$923K Sell
26,514
-201
-0.8% -$7.05K 0.88% 29
2020
Q2
$829K Buy
26,715
+16
+0.1% +$544 0.85% 30
2020
Q1
$827K Sell
26,699
-302
-1% -$10.3K 1.06% 24
2019
Q4
$1M Buy
27,001
+12
+0% +$427 0.96% 27
2019
Q3
$920K Buy
26,989
+15
+0.1% +$545 0.78% 26
2019
Q2
$1.11M Buy
26,974
+112
+0.4% +$4.45K 0.97% 19
2019
Q1
$1.08M Sell
26,862
-95
-0.4% -$3.81K 0.98% 18
2018
Q4
$1.12M Buy
26,957
+9
+0% +$374 1.15% 12
2018
Q3
$1.13M Sell
26,948
-336
-1% -$12.9K 0.99% 18
2018
Q2
$938K Buy
27,284
+13
+0% +$444 0.87% 22
2018
Q1
$921K Buy
+27,271
New +$938K 1.18% 20

Other funds holding PFE

Quad-Cities Investment Group's PFE Position: Q2 2024 in Review

Quad-Cities Investment Group sold out of Pfizer (PFE) in Q2 2024, closing a stake of 20,487 shares — an estimated $569K sold.

Quad-Cities Investment Group first reported a position in PFE in Q1 2018 and held it in 25 quarters. The position peaked at $1.45M in Q4 2021. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Quad-Cities Investment Group reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Quad-Cities Investment Group sold 20,487 Pfizer shares in Q2 2024, an estimated $569K.
  • Quad-Cities Investment Group first reported a position in Pfizer in Q1 2018 and held it in 25 quarters.
  • Quad-Cities Investment Group's Pfizer position peaked at $1.45M in Q4 2021.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Quad-Cities Investment Group's 13F filing for Q2 2024, filed 12 Jul 2024.